164 related articles for article (PubMed ID: 23222526)
1. Association between performance measures and glycemic control among patients with diabetes in a community-wide primary care cohort.
Sidorenkov G; Voorham J; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
Med Care; 2013 Feb; 51(2):172-9. PubMed ID: 23222526
[TBL] [Abstract][Full Text] [Related]
2. Trajectories of Glycemic Change in a National Cohort of Adults With Previously Controlled Type 2 Diabetes.
McCoy RG; Ngufor C; Van Houten HK; Caffo B; Shah ND
Med Care; 2017 Nov; 55(11):956-964. PubMed ID: 28922296
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the relationship between diabetes treatment intensification and quality measure performance using electronic medical records.
Arnold RJG; Yang S; Gold EJ; Farahbakhshian S; Sheehan JJ
PLoS One; 2018; 13(6):e0199011. PubMed ID: 29894495
[TBL] [Abstract][Full Text] [Related]
4. Impact of time to treatment intensification on glycemic goal attainment among patients with type 2 diabetes failing metformin monotherapy.
Rajpathak SN; Rajgopalan S; Engel SS
J Diabetes Complications; 2014; 28(6):831-5. PubMed ID: 25104238
[TBL] [Abstract][Full Text] [Related]
5. A longitudinal study examining adherence to guidelines in diabetes care according to different definitions of adequacy and timeliness.
Sidorenkov G; Haaijer-Ruskamp FM; de Zeeuw D; Denig P
PLoS One; 2011; 6(9):e24278. PubMed ID: 21931669
[TBL] [Abstract][Full Text] [Related]
6. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
7. Association Between Baseline Glycemic Markers (HbA1c) and 8-Year Trajectories of Functional Disability.
Mutambudzi M; Díaz-Venegas C; Menon S
J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1828-1834. PubMed ID: 30958520
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
[TBL] [Abstract][Full Text] [Related]
9. Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program.
Wang K; Zhao S; Lee EK; Yau SZ; Wu Y; Hung CT; Yeoh EK
JAMA Netw Open; 2024 Feb; 7(2):e2355733. PubMed ID: 38345817
[TBL] [Abstract][Full Text] [Related]
10. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
11. Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes.
Lu J; Wang C; Cai J; Shen Y; Chen L; Zhang L; Lu W; Zhu W; Hu G; Xia T; Zhou J
J Clin Endocrinol Metab; 2021 Oct; 106(11):3160-3167. PubMed ID: 34279663
[TBL] [Abstract][Full Text] [Related]
12. Change in HbA1c associated with treatment intensification among patients with type 2 diabetes and poor glycemic control.
Fu AZ; Sheehan JJ
Curr Med Res Opin; 2017 May; 33(5):853-858. PubMed ID: 28166431
[TBL] [Abstract][Full Text] [Related]
13. Impact of Glycemic Control on Risk of Infections in Patients With Type 2 Diabetes: A Population-Based Cohort Study.
Mor A; Dekkers OM; Nielsen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
Am J Epidemiol; 2017 Jul; 186(2):227-236. PubMed ID: 28459981
[TBL] [Abstract][Full Text] [Related]
14. Predictors of HbA1c levels in patients initiating metformin.
Martono DP; Hak E; Lambers Heerspink H; Wilffert B; Denig P
Curr Med Res Opin; 2016 Dec; 32(12):2021-2028. PubMed ID: 27552675
[TBL] [Abstract][Full Text] [Related]
15. Association of Potentially Modifiable Diabetes Care Factors With Glycemic Control in Patients With Insulin-Treated Type 2 Diabetes.
Lauffenburger JC; Lewey J; Jan S; Lee J; Ghazinouri R; Choudhry NK
JAMA Netw Open; 2020 Jan; 3(1):e1919645. PubMed ID: 31968115
[TBL] [Abstract][Full Text] [Related]
16. Patient characteristics do not predict poor glycaemic control in type 2 diabetes patients treated in primary care.
Goudswaard AN; Stolk RP; Zuithoff P; Rutten GE
Eur J Epidemiol; 2004; 19(6):541-5. PubMed ID: 15330126
[TBL] [Abstract][Full Text] [Related]
17. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
18. Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT database.
Sidorenkov G; Voorham J; de Zeeuw D; Haaijer-Ruskamp FM; Denig P
BMJ Qual Saf; 2013 Apr; 22(4):339-47. PubMed ID: 23386729
[TBL] [Abstract][Full Text] [Related]
19. The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes.
Rivera-Ávila DA; Esquivel-Lu AI; Salazar-Lozano CR; Jones K; Doubova SV
BMC Endocr Disord; 2021 Apr; 21(1):79. PubMed ID: 33888117
[TBL] [Abstract][Full Text] [Related]
20. High hemoglobin A
Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
